Discover the latest insights in the "Respiratory Syncytial Virus (RSV) Infections - Global Clinical Trials Review, 2025." This comprehensive report details RSV clinical trial data, including trial ...

Pregnant women have been urged to get a vaccination for respiratory syncytial virus (RSV) after a record number of cases in Australia.

Despite adequate availability of nirsevimab, only about one third of eligible children receive it for respiratory syncytial ...

The risk for respiratory syncytial virus-related hospitalizations is elevated in children with chronic medical conditions ...

Renee Taylor relates her experiences as a dysphagia-specialist speech-language therapist working in aged care. She looks at what can be done to minimise risks and enhance quality of life for ...

(OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company pioneering innovative therapies for viral diseases, is pleased to announce significant progress in development of its ...

In a retrospective study published in the Journal of the American Geriatrics Society, adults aged 65 and older hospitalized for RSV in Ontario, Canada experienced significantly higher rates of adverse ...

Australia saw a record number of RSV cases last year, and NHS officials have suggested that the Australian winter often ...

The respiratory syncytial virus (RSV) vaccine, introduced across the UK in late summer 2024, led to a 72% reduction in babies hospitalised with the virus if mothers were vaccinated, a new study has ...

BENGALURU: Although respiratory syncytial virus (RSV) causes nearly two-thirds of respiratory infections in infants, very few cases are reported in India, according to paediatric experts.

Palivizumab, when given through the veins or into a muscle (systemically), reduces hospitalisations due to respiratory syncytial virus (RSV) and reduces respiratory problems later on (chest wheezing), ...